Target intelligence / Profile preview

Gram-positive and Gram-negative anaerobes

Molecular classification
Other
01

Overview

"Gram-positive and Gram-negative anaerobes" refers collectively to bacterial species that do not require oxygen for growth and are categorized by their cell wall structure into Gram-positive or Gram-negative types using the Gram staining technique[1][7]. - Gram-positive anaerobes include genera such as Peptostreptococcus, Clostridium, and Actinomyces, generally characterized by a thick peptidoglycan layer in the cell wall[1][9]. - Gram-negative anaerobes include genera such as Bacteroides, Fusobacterium, and Prevotella, typically with a thin peptidoglycan layer and an outer membrane[1][7]. - These organisms are clinically significant causes of anaerobic infections (e.g., abscesses, bacteremia, tissue necrosis), often in mixed infections, and require antimicrobial susceptibility testing to guide therapy due to variable resistance patterns[2][5][6][8]. - They represent heterogeneous groups rather than a unique, targetable protein/receptor/molecule; thus, the term is not appropriate for molecular target databases.

Other names
Gram-positive anaerobic bacteriaGram-negative anaerobic bacteriaanaerobic bacteria
02

Mechanism of action

Inhibition of cell wall synthesis (e.g., beta-lactams); inhibition of protein synthesis (e.g., clindamycin, tetracyclines); DNA damage (e.g., metronidazole)

03

Biological functions

Other
04

Disease associations

Infection
05

Safety considerations

Development of antibiotic resistance among anaerobes, particularly in Bacteroides fragilis and related speciessome drugs (e.g., chlorampenicol) have narrow safety marginsprolonged therapy and surgical intervention may be needed
06

Interacting drugs

Metronidazole

10 more in the full profile.

Beyond the preview

Go deeper on Gram-positive and Gram-negative anaerobes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gram-positive and Gram-negative anaerobes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call